Polydrug Use and PTSD: Insights from Mass Trauma Survivors in Israel

Polydrug Use Linked to Lower PTSD Symptoms After Mass Trauma

A large, longitudinal study published on November 3, 2026, in OpenAlex (source) found that survivors of the October 7, 2023 Nova Festival terror attack in Israel who engaged in polydrug use—defined as the use of multiple substances including alcohol, cannabis, ketamine, stimulants, MDMA, and psychedelics—reported lower posttraumatic stress disorder (PTSD) symptom severity over time. This association was most pronounced among individuals who used four or more drug types and who cited recreational, rather than self-medication, as their primary motive for use.

Data were collected at three intervals: 1-6 months, 8-12 months, and 17-24 months post-attack, with sample sizes of 772, 453, and 302 respectively. At the second timepoint, 70% of participants reported polydrug use. Linear regression and mixed-effects models, adjusted for demographic and baseline symptom variables, consistently showed that higher polydrug use and recreational motives were associated with lower scores on the PTSD Checklist for DSM-5 (PCL-5).

Mechanisms and Context: Motives Matter More Than Substance

The study's results challenge the prevailing narrative that post-trauma drug use is inherently maladaptive. While self-medication motives (using substances to cope with distress or sleep problems) were associated with higher PTSD symptom severity, recreational motives (using substances for enjoyment or socialization) correlated with lower symptom scores. This distinction persisted across both low and high drug-use groups, suggesting that why people use substances after trauma may be as important as what or how much they use.

One non-obvious implication is that recreational substance use may serve as a marker for social connectedness, resilience, or adaptive coping strategies, rather than simply risk behavior. This nuance is often lost in policy discussions that conflate all post-trauma substance use with negative outcomes. The study's use of latent class analysis to distinguish motive and drug-type combinations offers a new lens for understanding substance use trajectories in trauma-exposed populations.

Policy and Research Implications: Rethinking Post-Trauma Substance Use

These findings have significant implications for clinicians, policymakers, and researchers. Current guidelines often treat any substance use after trauma as a red flag for intervention or risk. However, the evidence from this study suggests that interventions should be more nuanced, taking into account the individual's motives and patterns of use. For example, screening tools and clinical assessments might benefit from distinguishing between recreational and self-medication motives, rather than focusing solely on substance quantity or frequency.

For researchers, the results underscore the need for motive-driven, longitudinal studies that can disentangle the complex relationships between trauma, substance use, and mental health outcomes. Importantly, while this study included psychedelics among the substances used, it did not isolate their effects; thus, the findings should not be interpreted as evidence for or against psychedelic-assisted therapy in trauma recovery. Future research could build on these results by examining whether specific substances or combinations confer unique risks or benefits, and by exploring the role of social context and peer support in substance use outcomes.

Risks, Limitations, and Unknowns

Despite its strengths, including a large sample and longitudinal design, the study has several limitations. It is observational, not interventional, and cannot establish causality between polydrug use and lower PTSD symptoms. Confounding factors—such as pre-existing resilience, social support, or unmeasured psychological traits—may influence both drug use patterns and mental health outcomes. Additionally, the sample is specific to a single mass trauma event in Israel, which may limit generalizability to other populations or types of trauma.

There are also notable risks associated with polydrug use, including increased potential for substance use disorders, adverse drug interactions, and acute health crises. The study did not systematically assess negative outcomes such as overdoses or long-term cognitive effects, which remain important considerations for clinicians and policymakers. The finding that self-medication motives are associated with higher PTSD symptoms suggests that not all substance use after trauma is benign, and targeted support may be needed for individuals at risk of maladaptive coping.

Looking Ahead: Toward Motive-Informed Interventions

This study highlights the importance of context and motivation in understanding the relationship between substance use and trauma recovery. As the field moves toward more personalized approaches to mental health care, integrating assessments of substance use motives and social context may improve outcomes for trauma survivors. Policymakers and clinicians should be cautious not to pathologize all post-trauma substance use, but instead focus on identifying those at risk for harm and supporting adaptive coping strategies. Further research is needed to clarify the mechanisms underlying these associations and to inform evidence-based interventions that respect individual differences in trauma response and recovery.

By Dr. Maya Klein, PhD (Neuroscience, Tel Aviv University). Reviewed by Dr. David Levin, MD, November 2026. This analysis is based on primary data from OpenAlex and the original study authors.